Inhibitors of thrombin induced platelet aggregation

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/517 (2006.01) A61K 31/00 (2006.01) A61K 38/57 (2006.01) C07D 239/94 (2006.01)

Patent

CA 2392554

The present invention describes a therapeutic method useful for treating or preventing a condition of platelet aggregation in a subject including administering a pharmaceutically effective amount of a compound or composition that inhibits JAK-3 and/or tyrosine phosphorylation of STAT-3 and inhibits thrombin induced platelet aggregation. The condition of platelet aggregation includes hematopoietic and cerebrovascular diseases.

La présente invention concerne une technique thérapeutique destinée au traitement ou à la prévention d'une agrégation de plaquettes chez un sujet, qui consiste à administrer une quantité pharmaceutiquement efficace d'un composé ou d'une composition, laquelle inhibe JAK-3 et/ou la phosphorylation tyrosine de STAT-3 et inhibe ainsi l'agrégation de plaquettes. Parmi les pathologies liées à cette agrégation de plaquette figurent les maladies hématopoïétiques et cérébro-vasculaires.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Inhibitors of thrombin induced platelet aggregation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibitors of thrombin induced platelet aggregation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of thrombin induced platelet aggregation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1749579

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.